Search ASX code:
Generic filters

Kogan.com (ASX:KGN) keeps growing at an impressive pace

Kogan.com Ltd (ASX: KGN) is holding its AGM today and unveiled more impressive growth to the end of October 2020.

Kogan’s big trading update

For the first four months of FY20, to October 2020, Kogan.com has seen continued fast growth.

Kogan revealed that in the financial year to date, gross sales increased by 99.8%, gross profit went up 131.7% and adjusted EBITDA (EBITDA explained) has grown by 268%.

The e-commerce business said that it has seen a strong performance from its product divisions and Kogan Marketplace.

Kogan is now entering the strongest trading part of the year, which is important for the performance of the entire financial year.

The company also said it has been investing heavily in variable and marketing costs which is aimed to increase the customer base and brand, which it expects will deliver long term benefits for the company.

Time to buy Kogan.com shares?

The Kogan.com share price has dropped almost 20% over the past month. Some investors are worried that the online sales trend will reverse as a COVID-19 vaccine is deployed to the population.

In my opinion, the growth momentum may slow a little in the 2021 calendar year, but the trend towards online products and services was increasing even before COVID-19 came along. Most of the country hasn’t been limited by COVID-19 restrictions in FY21 – physical stores are open – yet Kogan has delivered the growth outlined above.

With Australia’s low interest rate, I think Kogan’s current share price valuation of around $18 still makes sense for a long term buy. A growing dividends helps boost shareholder returns.

I also like other ASX growth shares such as Pushpay Holdings Ltd (ASX: PPH).

1 ASX Stock to Buy RIGHT NOW...

Our top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond.

Click here or enter your email address below to access the stock code, 3,500-word analysis and founder interview. Our top expert's free investment reports are exactly that -- completely free! No gimmicks, just expert-proofed stock research and more.

Enter your email below to receive his free report.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

1 ASX Stock to Buy RIGHT NOW...

Our top analyst has just identified his #1 'MedTech' stock idea for 2021 and beyond.

Click here to access the stock code, 3,500-word analysis and founder interview. Our top expert's investment reports are completely free with a Rask Australia account. No gimmicks, just free stock research and more. Click here now to get the report.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Keep reading: